Pharmacolog granted new European patent
Pharmacolog AB have received a patent approval from the European Patent Office, EPO, regarding method and technology for adaptive dose regulation in connection with intravenous drug treatments.In 2018, the US Patent Office approved the Company's patent application regarding the method and system for dose control of the drug concentration in the infusion liquid during treatment. The company has now obtained the corresponding patent in Europe. The patent applies to dose control based on physiological and biological response parameters such as temperature, respiration, biomarkers in various